Skip to main content

ECOFIBRE’S ANANDA HEALTH DIVISION and MEDISCA Announce Exclusive Partnership for Global Distribution of Full Spectrum CBD

Written by Customer Service on . Posted in Public Companies.

Georgetown, KY, Jan. 19, 2021 (GLOBE NEWSWIRE) — Ecofibre’s Ananda Health Division, the leading provider of CBD to US independent pharmacies is pleased to announce that it has partnered with MEDISCA to be the exclusive pharmaceutical compounding distributor of Ananda Professional products in the United States, Canada and Australia. David Neu, CEO of Ananda Health states, “We could not be more proud to partner with the global leader in the pharmaceutical compounding industry.  MEDISCA has over 30 years of experience in the industry and both of our organizations have core values that are deeply aligned around education, quality and customer care.”“MEDISCA has been closely monitoring the CBD segment over the past several years and we have seen awareness and demand increase for compounding pharmacists across many geographies.  To ensure that we can provide our pharmacists the best-in-class CBD product range we are very pleased to announce our exclusive distribution partnership with Ananda Health,” said Panagiota Danopoulos, SVP Global Strategy and Innovation at MEDISCA.“CBD is an exciting new category that still requires significant research and education to ensure it can help as many patients as possible.  In conjunction with Ananda Health, we are very excited to be able to give our pharmacists access to the research, tools and training to improve patient outcomes, “said Ms. Danopoulos.Neu continued “This partnership is one of the most important milestones in the professionalization of the CBD industry.  This is the first time a multinational distributor will be carrying ingestible hemp-derived CBD products.”The full range of Ananda Professional products will be available via the MEDISCA network beginning February 1, 2021.About Ananda HealthIn the United States, Ananda Health is the #1 provider of hemp-derived CBD for retail pharmacies.  The Company produces nutraceutical products for human and pet consumption, as well as topical creams and salves.  See www.anandahemp.com and www.anandaprofessional.com.  The Company also supplies its leading Ananda Hemp CBD products to Australians via the SAS B program. The Company owns or controls key parts of the value chain in each business, from breeding, growing and production to sales and marketing.  Our value proposition to customers is built on strong brands and quality products.About MEDISCAMEDISCA is the leader in providing turnkey solutions to the pharmaceutical compounding industry and allied health care professionals worldwide. Through its global partners, LP3 Network and MEDISCA Network, MEDISCA is committed to being a complete resource for prescribers, pharmacists and pharmacy technicians engaged in personalized medicine by offering educational trainings, products, and support. Founded in 1989, the company has locations in Canada, the United States and Australia, optimizing its service to the international market. For more information about MEDISCA, please visit www.medisca.com and follow us on Twitter at @medisca.                                                                                                        ###David Neu
Ananda Health
David.neu@anandahealth.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.